Clinical Trial Update: Effect of Radiofrequency in the Treatment of de Novo Dyspareunia at 4 to 16 Months Postpartum. [NA]

View source ↗

Summary

An ongoing clinical trial is evaluating the use of radiofrequency treatment for de novo dyspareunia in women 4 to 16 months postpartum. The sponsor is Hospital …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspareunia

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Dyspareunia | NA | Status: RECRUITING